Form EFFECT Serina Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 31, 2026 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lift Procedures Led Growth as Demand for Restoration Drove Plastic Surgery in 2025, New ASPS Report Reveals
- Sargento Celebrates 2025 Achievements in Real Impact Report
- Medical Care Technologies Inc. (OTCID:MDCE) Centers StrainScan Pro on Multi-Trillion-Dollar Agriculture and Foodservice Markets
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share